cxsymposium

The Charing Cross Symposium (CX), London, is the longest running vascular and endovascular symposium in Europe and one of the largest in the world.

The first CX had 100 attendees. In 2017, the Charing Cross Symposium - Consensus Update had 4,125 participants, from 84 countries, making it a leading global event.

CX mission

The Charing Cross Symposium raises vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle. Controversies will be discussed in 2018.

CX programme and format

All Charing Cross Symposia are distinguished by a unique and logical programme, which focuses on identifying evidence for optimal vascular disease management from head to toe, catering for all vascular specialists.

Debate and emphasis on interaction with an expert audience are key aspects of the CX’s style. Education, Innovation and Evidence are CX core values.

Short presentations and time keeping are key characteristics of the CX sessions; these enable the right time for comments and questions by the audience.

CX App

All registered CX attendees will be given access to the app a few weeks before the Symposium, allowing them to network with fellow physicians, industry professionals and the faculty. The programmes will be available, with the option to create your own personal agenda for the meeting by adding selected sessions to Favourites.

In 2018 we will also be using the app for in-session audience polling.